View Cart
My AccountInfectious Disease Diagnostic Solutions
Microbix Phone+1803294983432Microbix Emailcustomer.service@microbix.com
Microbix Logo
Request Catalogue Contact Us
  • Services
    • Assay Development Solutions
    • Custom Vial Filling Services
  • Products
    • Reference Materials (QUANTDx™)
    • Antigens
      • All Antigens
      • Childhood Disease Antigens
      • Dengue Antigens
      • STI Antigens
      • ToRCH Antigens
      • Respiratory Antigens
      • Other Antigens
    • External Quality Controls (QAPs™)
      • All External QC Products
      • Respiratory Viral Panel
      • STI Panel
      • HPV Panel
      • Gastrointestinal Panel
      • Genital Ulcer Panel
      • Vaginal Infections Panel
      • ONBOARDx Kits
      • Proficiency Testing Panel
      • Technical Resources
    • DxTM™ Viral Transport Medium
    • Control Elution Buffer
    • Kinlytic (Urokinase)
  • About
    • Who We Are
    • Who We Work With
    • Quality
    • Board of Directors
    • Our Senior Team
    • Careers
  • Resources
    • White Papers
    • Poster Publication
    • Podcasts
  • Investors
    • News Releases
    • Financial Reports
    • Corporate Presentations
    • Analyst Coverage
    • Corporate Governance
    • Stock Information
Contact Us
Microbix’s Clot-Buster Drug Project Advances

Microbix’s Clot-Buster Drug Project Advances

by Aayat Punjabi | May 5, 2025 | Blog, Media Features News Releases, News Releases

Sequel Pharma Executes Agreement with CDMO for Drug Product Manufacturing   MISSISSAUGA, CANADA, May 5, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that its funding and...
Microbix Presenting at the 2025 Bloom Burton Conference

Microbix Presenting at the 2025 Bloom Burton Conference

by Shitika Kulshreshtha | May 1, 2025 | Blog, Media Features News Releases, News Releases

Microbix Presenting at the 2025 Bloom Burton Conference   MISSISSAUGA, ONTARIO, May 1, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it will be attending and presenting...
Microbix Exhibiting at ESCMID Global 2025

Microbix Exhibiting at ESCMID Global 2025

by Shitika Kulshreshtha | Apr 9, 2025 | Blog, Media Features News Releases, News Releases

Microbix Showcasing novel QAPs, Customer Presenting Pilot EQA Program Results   MISSISSAUGA, CANADA, April 9, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it will be...
Microbix Provides Business Updates

Microbix Provides Business Updates

by Shitika Kulshreshtha | Apr 8, 2025 | Blog, Media Features News Releases, News Releases

 U.S. & Reciprocal Tariff Outcomes, Second-Half 2025 Outlook   MISSISSAUGA, April 8, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF) (“Microbix®” or the Company”), a life sciences innovator, manufacturer, and exporter, provides an update on...
Microbix Announces Annual and Special Meeting Voting Results

Microbix Announces Annual and Special Meeting Voting Results

by Shitika Kulshreshtha | Mar 27, 2025 | Blog, Media Features News Releases, News Releases

MISSISSAUGA, March 27, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF) (“Microbix®” or the Company”), a life sciences innovator and exporter, announces the voting results from the Annual and Special Meeting of Shareholders of the Company (the “Meeting”)...
Microbix Further Optimizes Capital Usage and Availability

Microbix Further Optimizes Capital Usage and Availability

by Shitika Kulshreshtha | Mar 26, 2025 | Blog, Media Features News Releases, News Releases

Debt Repayment & Credit Expansion Provides Savings & Maintains Resilience   MISSISSAUGA, CANADA, March 26, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces the further...
« Older Entries
Next Entries »
  • Investors
  • Legal
  • Contact
  • News Releases
  • Accessibility
  • Careers
Microbix Funded By